Use of hyperbaric oxygen therapy and PEGylated carboxyhemoglobin bovine in a Jehovah’s Witness with life-threatening anemia following postpartum hemorrhage by Prolong Pharma | Feb 1, 2017 | Publications
Hemoglobin-based blood substitutes and the treatment of sickle cell disease: More harm than help? by Prolong Pharma | Jan 1, 2017 | Publications